Wide Ranks

FBRX

Forte Biosciences, Inc.

19.79

Top Statistics
Market Cap 28 M Forward PE -5.20 Revenue Growth 0.00 %
Current Ratio 2.82 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 24 M Total Cash Per Share 16.78 Total Debt
Total Debt To Equity Current Ratio 2.82 Book Value Per Share 24.30
All Measures
Short Ratio 9.00 % Message Board Id finmb_594626683 Shares Short Prior Month 3263
Return On Equity -1.71 City Dallas Uuid f04f9b0f-d548-36f2-85cf-42c97dc26955
Previous Close 16.68 First Trade Date Epoch Utc 1 B Book Value 24.30
Beta 1.46 Volume 273275 Price To Book 0.8145
Last Split Date 1 B Fifty Two Week Low 4.11 Total Cash Per Share 16.78
Shares Short Previous Month Date 1 B Target Median Price 107.00 Max Age 86400
Recommendation Mean 1.00 Sand P52 Week Change 0.3133 Target Mean Price 107.00
Net Income To Common -35758000 Short Percent Of Float 0.0007 Implied Shares Outstanding 1 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 3 M
Average Volume10days 3 M Total Cash 24 M Next Fiscal Year End 1 B
Held Percent Insiders 0.1094 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 16.68 Target Low Price 64.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 6.55 Open 17.50
Free Cashflow -18242876 State TX Dividend Yield 0.00 %
Return On Assets -0.8125 Time Zone Short Name EST Trailing Eps -16.38
Day Low 16.86 Address1 3060 Pegasus Park Drive Shares Outstanding 1 M
Price Hint 2 Target High Price 150.00 Website https://www.fortebiorx.com
52 Week Change 0.6700 Average Volume 507700 Forward Eps -18.25
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 268.70 %
Last Split Factor 1:25 Regular Market Day High 23.36 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 23.36 Day High 23.36
Shares Short 982 Regular Market Open 17.50 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0007
Operating Cashflow -30630000 Currency USD Time Zone Full Name America/New_York
Market Cap 28 M Is_nasdaq_100 False Zip 75247
Quote Type EQUITY Industry Biotechnology Long Name Forte Biosciences, Inc.
Regular Market Day Low 16.86 Held Percent Institutions 0.5405 Current Price 19.79
Address2 Building 6 Financial Currency USD Current Ratio 2.82
Industry Disp Biotechnology Number Of Analyst Opinions 2 Country United States
Float Shares 882257 Two Hundred Day Average 12.44 Enterprise Value -15970677
Forward PE -5.20 Regular Market Volume 273275 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States.

The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata.

Forte Biosciences, Inc. is headquartered in Dallas, Texas.